Skip to main content


Table 1 Nivolumab and immune related adverse events

From: Autoimmune rhabdomyolysis and a multiorgan display of PD-1 inhibitor induced immune related adverse events during treatment of metastatic melanoma

irAEs associated with nivolumab Patient findings
Myalgias and arthralgias Rhabdomyolysis
Hyperthyroidism Elevated TSH
Ocular side effects Keratoconjunctivitis
Hepatotoxicity Transaminitis
Myocarditis Troponin leak
Pleural effusion Left lung consolidation with effusion
Myasthenia Gravis Progressive weakness (related?)